Please ensure Javascript is enabled for purposes of website accessibility

Ventas Sparks Health Care REITs

By Billy Fisher – Updated Nov 15, 2016 at 5:40PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ventas turns in impressive earnings and emerges as a heavy hitter in the health-care REIT sector.

While apartment and office-space rentals have been the center of attention from a big summer for real estate investment trusts, health care REITs have also continued to experience steady gains. Ventas (NYSE:VTR) has emerged as one of the heavy hitters in the sector, turning in impressive earnings and enriching its shareholders with a 4.1% dividend yield. With a market capitalization of just more than $4 billion, the company finances, owns, and leases health care-related and senior housing facilities in 42 states.

For the Kentucky-based REIT's second quarter ending June 30, 2006, Ventas reported funds from operations (FFO) of $59.5 million. These earnings represented a 30% increase from its year-ago second quarter. The company subsequently revised its full-year FFO guidance to $2.25 to $2.27 per share, up from previous guidance of $2.23 to $2.25 per share. The rise in earnings is primarily attributable to increased rent; Ventas saw its rental income leap from $72.3 million to $99.1 million year over year.

The REIT has seen its stock price escalate 24.8% over the past twelve months. The climb has had less to do with speculation than with a series of quarters in which the company has delivered stellar earnings growth to its shareholders. The success has been punctuated by quarterly year-over-year revenue growth of 33.8%, and a return on equity of 19.76%. Ventas chairman, president, and CEO Debra A. Cafaro stated, "We remain one of the top-performing REITs with our eleven consecutive quarters of double digit normalized FFO per share growth and continued execution of our strategic diversification plan."

At a price/FFO ratio of 16.55, the company is reasonably priced with respect to competitors Health Care Property Investors (NYSE:HCP) and Healthcare Realty Trust (NYSE:HR), which carry price/FFO ratios of 15.33 and 16.92, respectively. Economic conditions are favorable for the industry in general. Robert M. Mains, an analyst for Ryan Beck & Co., recently retained an "Outperform" rating for Ventas, nothing that state Medicaid rates paid to nursing homes are up 2% to 3%, with most rate increases beginning July 1, and that Medicare payments are set to rise on Oct.1, by 2.7% to 3.2% for nursing homes.

Ventas management has maintained a proactive stance in terms of earnings growth, recently announcing a $649 million deal to acquire 67 health-care and senior-housing properties in 16 states. This move should help to sustain future earnings growth at a level at which Ventas shareholders have grown accustomed. Fools might want to look at this health-care REIT as a less volatile alternative to apartment and office-space REITs, since it should prove less reliant on a thriving U.S. economy.

For further Foolishness:

Can't get enough investment advice? Try any of the Fool's newsletters free for 30 days.

Fool contributor Billy Fisher does not own shares of any of the companies mentioned.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Ventas, Inc. Stock Quote
Ventas, Inc.
VTR
$43.43 (-2.51%) $-1.12
HCP, Inc. Stock Quote
HCP, Inc.
PEAK
$24.28 (-1.10%) $0.27
Healthcare Realty Trust Incorporated Stock Quote
Healthcare Realty Trust Incorporated
HR

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.